CHEMCEL BIOTECH LTD.

NSE : NABSE : 533026ISIN CODE : INE213J01012Industry : Pesticides & AgrochemicalsHouse : Private
BSE0.950 (0 %)
PREV CLOSE ( ) 0.95
OPEN PRICE ( ) 0.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.95 (117664)
VOLUME 16090
TODAY'S LOW / HIGH ( )0.95 0.95
52 WK LOW / HIGH ( ) 0.950.95
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2011Mar2010Mar2009Mar2008
Profit Before Tax11.3017.6117.2716.31
Adjustment-2.03-3.25-3.43-2.87
Changes In working Capital-46.92-64.13-154.6747.35
Cash Flow after changes in Working Capital-37.66-49.76-140.8360.79
Cash Flow from Operating Activities-37.66-49.76-140.8360.79
Cash Flow from Investing Activities2.562.47-86.655.73
Cash Flow from Financing Activities34.7846.94226.75-65.22
Net Cash Inflow / Outflow-0.32-0.36-0.731.30
Opening Cash & Cash Equivalents0.350.701.430.13
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANA
Effect of Foreign Exchange FluctuationsNANANANA
Closing Cash & Cash Equivalent0.030.350.701.43

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.